Short Interest in Bonk, Inc. (NASDAQ:BNKK) Rises By 761.1%

Posted by on May 29th, 2026

Bonk, Inc. (NASDAQ:BNKK – Get Free Report) was the target of a significant increase in short interest during the month of May. As of May 15th, there was short interest totaling 834,243 shares, an increase of 761.1% from the April 30th total of 96,882 shares. Based on an average daily volume of 724,730 shares, the short-interest ratio is currently 1.2 days. Approximately 21.5% of the shares of the company are short sold.

Bonk Price Performance

NASDAQ BNKK traded up $0.23 during trading on Friday, reaching $1.99. The company’s stock had a trading volume of 1,410,690 shares, compared to its average volume of 962,500. The stock has a market capitalization of $15.90 million, a PE ratio of -0.41 and a beta of 1.97. The firm has a fifty day moving average of $2.45 and a 200 day moving average of $3.57. Bonk has a one year low of $1.53 and a one year high of $46.90.

Bonk (NASDAQ:BNKK – Get Free Report) last released its quarterly earnings results on Wednesday, May 13th. The company reported ($0.23) EPS for the quarter. Bonk had a negative return on equity of 148.62% and a negative net margin of 838.37%.The company had revenue of $0.79 million during the quarter.

Analysts Set New Price Targets

A number of research firms recently weighed in on BNKK. Weiss Ratings lowered shares of Bonk from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, April 29th. Wall Street Zen upgraded shares of Bonk from a “sell” rating to a “hold” rating in a research note on Saturday, May 16th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock presently has a consensus rating of “Sell”.

Check Out Our Latest Stock Report on Bonk

Insider Transactions at Bonk

In other news, Director Mitchell Austin Rudy acquired 31,055 shares of the stock in a transaction that occurred on Thursday, April 9th. The shares were acquired at an average cost of $2.82 per share, for a total transaction of $87,575.10. Following the purchase, the director owned 44,198 shares of the company’s stock, valued at approximately $124,638.36. The trade was a 236.29% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 51.60% of the company’s stock.

Institutional Investors Weigh In On Bonk

Several hedge funds have recently added to or reduced their stakes in BNKK. State Street Corp bought a new stake in Bonk during the fourth quarter worth about $33,000. Steward Partners Investment Advisory LLC bought a new stake in Bonk during the 4th quarter valued at $37,000. Jane Street Group LLC bought a new position in shares of Bonk during the fourth quarter valued at about $96,000. Finally, Geode Capital Management LLC bought a new position in shares of Bonk during the fourth quarter valued at about $128,000. Institutional investors own 12.55% of the company’s stock.

Bonk Company Profile

(Get Free Report)

Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc and changed its name to Safety Shot, Inc in September 2023.

Featured Articles

Receive News & Ratings for Bonk Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bonk and related companies with MarketBeat.com's FREE daily email newsletter.